Avnet and IDEMIA Develop Highly Flexible ‘Plug & Play’ Cellular Connectivity Solution for IoT and Industry 4.0 Applications
Avnet (NYSE: AVT), a leading global technology distributor and IDEMIA (formerly known as OT-Morpho), the global leader in Augmented Identity, have joined forces to collaborate on the development of a new future-proof cellular connectivity solution that meets the growing communication requirements for Internet of Things (IoT) and Industry 4.0 applications.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180222005966/en/
(Photo: IDEMIA)
The new ‘plug & play’ eUICC (embedded Universal Integrated Circuit Card) and SM-SR (Subscription Management Secure Routing) delivers product future-proofing capability to IoT application solution providers and other businesses. It provides them with the ability to easily choose a mobile network operator (MNO) without eventually having to manually change the embedded SIM card in their cellular connectivity-based devices, machines and sensors that are already deployed in the field. The product bundle is also unique as it already includes an initial prepaid cellular connectivity allowance with a cellular carrier profile that has been downloaded to the eUICC during the manufacturing stage.
“Across multiple industrial segments, the embedded SIM adoption is tremendous, driven primarily by critical benefits amongst the device lifecycle connectivity management, sustainability in harsh environment and deployment simplification,” said Yves Portalier, executive vice president for connected objects activities at IDEMIA. “Several market segments such as automotive are already growing fast, so by combining the strengths of IDEMIA, Avnet and our connectivity partners, we can help to drive the adoption of this solution to all IoT use cases and applications.”
Avnet Silica will be the first division of Avnet to deploy the solution and will manage the delivery, integration and service operations for an estimated 10,000 industrial customers requiring cellular support services.
Lou Lutostanski, vice president global IoT for Avnet said, “Through this combined IoT solution with IDEMIA, we enable all our customers -- as well as their customers-- to design future-proof ‘plug & play’ cellular-connected solutions. This optimizes and ensures competitive advantages including secure and flexible global connectivity with our mobile network operator partners. Our unique business-model solution makes this high-end state-of-the-art technology affordable for each of our customers, regardless of their size.”
The jointly-developed Avnet Silica and IDEMIA solution is fully compliant with Avnet’s global IoT program that offers end-to-end solutions to guide customers from idea through every stage of their design. Avnet’s IoT smart solutions help organizations jump-start development of IoT-enabled products and systems for industrial, retail, healthcare, and other environments.
All brands and trade names are trademarks or registered trademarks, and are the properties of their respective owners. Avnet disclaims any proprietary interest in marks other than its own.
About IDEMIA
OT-Morpho is now IDEMIA, the global leader in
Augmented Identity for an increasingly digital world, with the ambition
to empower citizens and consumers alike to interact, pay, connect,
travel and vote in ways that are now possible in a connected environment.
Securing
our identity has become mission critical in the world we live in today.
By standing for Augmented Identity, we reinvent the way we think,
produce, use and protect this asset, whether for individuals or for
objects. We ensure privacy and trust as well as guarantee secure,
authenticated and verifiable transactions for international clients from
Financial, Telecom, Identity, Public Security and IoT sectors.
OT
(Oberthur Technologies) and Safran Identity & Security (Morpho) have
joined forces to form IDEMIA. With close to $3 billion in revenues and
14,000 employees around the world, IDEMIA serves clients in 180
countries. For more information, visit www.idemia.com /
Follow @IdemiaGroup on Twitter.
About Avnet
From idea to design and from prototype to
production, Avnet supports customers at each stage of a product’s
lifecycle. A comprehensive portfolio of design and supply chain services
makes Avnet the go-to guide for innovators who set the pace for
technological change. For nearly a century, Avnet has helped its
customers and suppliers around the world realize the transformative
possibilities of technology. Learn more about Avnet at: www.avnet.com.
Follow Avnet on Twitter: @Avnet
Connect
with Avnet on LinkedIn: http://www.linkedin.com/company/avnet
Connect
with Avnet on Facebook: http://www.facebook.com/AvnetInc
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180222005966/en/
Contact information
Media
Maureen O’Leary, 480-643-7499
Director Media
Relations Avnet
maureen.oleary@avnet.com
or
Jamie
Ernst, 480-308-0286
Brodeur Partners, for Avnet
jernst@brodeur.com
or
Anja
Woithe, +49 (0) 8121 774 459
Senior PR Manager Avnet EMEA
Anja.woithe@avnet.eu
or
Hanna
Sebbah, +33 (0)6 63 73 30 30
Havas Paris PR Agency for IDEMIA
idemia@havas.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new
MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 15:00:00 EEST | Press release
The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin
IonQ Unanimously Appoints Peter Chapman as Next Chairman of the Board of Directors26.4.2024 14:30:00 EEST | Press release
IonQ (NYSE: IONQ), a leader in the quantum computing industry, announced today the appointment of Peter Chapman as its next Chairman of the Board and Harry You as the Lead Independent Director of the Board, effective at the close of IonQ’s upcoming Annual General Meeting on June 5, 2024. Both appointments were disclosed in a proxy statement issued on April 25, 2024. Peter Chapman has also been nominated for re-election as a Class III director at the meeting, and his chairmanship will take effect assuming he is re-elected. “Last quarter we were delighted to have appointed Robert Cardillo and Bill Scannell to our Board of Directors. In addition, the Board unanimously appointed Peter Chapman to serve as its next Chairman following the annual meeting given his half-decade worth of contributions to IonQ and his strong progress transitioning IonQ from an academic to a commercial company,” said Niccolo de Masi, Chairman of the Nominating & Corporate Governance Committee of IonQ’s Board. “Unde
Sealing System launches: XIO – Intelligent Farming26.4.2024 13:17:00 EEST | Press release
XIO – Intelligent Farming, specializes in logistics systems for insect protein production. XIO is a new business unit within Sealing System A/S, one of the leading providers of automated end-of-line packaging lines in Scandinavia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240426832303/en/ Robotic solution handling Black Soldier Fly Larvae (Photo: Business Wire) “At Sealing System A/S, we believe that practical innovation is the engine of real-world change. With the establishment of, XIO - Intelligent Farming, we are setting new industry standards, emphasizing the importance of intralogistics in the field of insect protein production, and proudly leading the way.” Ole Jensen CEO, Sealing System A/S XIO – Intelligent Farming provides solutions serving various aspects of the insect production, including fully automatic logistics systems, comprehensive data tracking, transfer trolleys and shuttles, as well as robot systems
Tecnotree Achieves Strong Q1 2024 Results with Sustained Revenue Growth and Enhanced Profitability26.4.2024 11:46:00 EEST | Press release
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced its financial results for the first quarter of 2024, demonstrating solid growth with a 4.7% increase in revenue. The company maintained its momentum in driving global sales of its digital platform, in the first quarter of 2024, completing many AIML and digital transformations to key customers, resulting in a significant increase in revenue. The growth was primarily driven by new wins in the LATAM region, while EMEA and APAC regions remain growing markets for the digital platform. Key Q1 Highlights of the financial results: Net sales increased 4.7% to EUR 16.3 (15.5) million. Operating results increased by 22.3% to EUR 4.4 (3.6) million. Earnings per share EUR 0.01 (0.01). Order book at the end of the period increased by 10.3% to EUR 74.8 (67.8) million. Tecnotree achieved several notable milestones in the first quarter. The company solidified its position as a trusted par
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom